A China-centered pharmaceutical company engaged in the study.

China Shenghuo’s Lixuwang product recieves Chinese Well-Known Trademark Honor China Shenghuo Pharmaceutical Holdings, Inc., a China-centered pharmaceutical company engaged in the study, development, manufacture, and advertising of Traditional Chinese Medicine , supplements and cosmetic products, today announced that ‘Lixuwang’, the trademark of its best selling item, Xuesaitong Capsule, was awarded the Chinese Well-Known Trademark Honor by the continuing state Administration for Industry and Commerce of China. This prestigious award recognizes Xuesaitong’s market leading placement; gives China Shenghuo access to additional government grants and the green path in anti-counterfeit marketing campaign; and increases the value of this significant intangible asset cialis sildénafil . ..


In the years ahead, we be prepared to pursue attractive brand-new markets opportunistically, such as EDL drugs, while managing our product blend carefully. Finally, furthermore to controlling our current portfolio of items for growth and profitability, this one fourth we continued to advance our pipeline, which includes several late-stage drug candidates which we believe could have got significant market potential.’ Second Quarter Results Second one fourth 2010 total revenues grew 22 percent to $16.6 million from $13.6 million in second quarter 2009. Digestive Diseases product sales for the next quarter 2010 grew by 129 percent year-over-12 months to $2.3 million, because of increased sales of Omeprazole primarily, our generic gastroesophageal reflux disease medication released in fourth quarter 2009.